Literature DB >> 2684507

Glycoconjugates of bacterial carbohydrate antigens. A survey and consideration of design and preparation factors.

W E Dick1, M Beurret.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2684507

Source DB:  PubMed          Journal:  Contrib Microbiol Immunol        ISSN： 0301-3081


× No keyword cloud information.
  16 in total

1.  Depletion of complement has distinct effects on the primary and secondary antibody responses to a conjugate of pneumococcal serotype 14 capsular polysaccharide and a T-cell-dependent protein carrier.

Authors:  Samuel T Test; Joyce K Mitsuyoshi; Yong Hu
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Determination of glycation sites by tandem mass spectrometry in a synthetic lactose-bovine serum albumin conjugate, a vaccine model prepared by dialkyl squarate chemistry.

Authors:  Farid Jahouh; Shu-jie Hou; Pavol Kováč; Joseph H Banoub
Journal:  Rapid Commun Mass Spectrom       Date:  2012-04-15       Impact factor: 2.419

3.  Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model.

Authors:  H K Guttormsen; L M Wetzler; R W Finberg; D L Kasper
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

Authors:  M R Wessels; L C Paoletti; D L Kasper; J L DiFabio; F Michon; K Holme; H J Jennings
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide.

Authors:  S T Test; J Mitsuyoshi; C C Connolly; A H Lucas
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Preparation, characterization, and immunogenicity of conjugate vaccines directed against Actinobacillus pleuropneumoniae virulence determinants.

Authors:  W Byrd; S Kadis
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

7.  Immunological properties of recombinant porin of Haemophilus influenzae type b expressed in Bacillus subtilis.

Authors:  R Srikumar; D Dahan; M F Gras; L Saarinen; H Käyhty; M Sarvas; L Vogel; J W Coulton
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

Review 8.  Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Authors:  A F Verheul; H Snippe; J T Poolman
Journal:  Microbiol Rev       Date:  1993-03

9.  Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates.

Authors:  A F Verheul; A K Braat; J M Leenhouts; P Hoogerhout; J T Poolman; H Snippe; J Verhoef
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

10.  Saccharide/protein conjugate vaccines for Bordetella species: preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugates.

Authors:  Joanna Kubler-Kielb; Evgeny Vinogradov; Gil Ben-Menachem; Vince Pozsgay; John B Robbins; Rachel Schneerson
Journal:  Vaccine       Date:  2008-05-20       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.